Cleveland Biolabs (Nasdaq: CBLI) announced approval from the Ministry of Health of the Russian Federation to start a Phase 1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE